Dietary
flavonoids are used in treatment of multiple diseases, and their antiinflammatory effects in the intestine are due, in part, to interactions with gut microflora and possibly due to modulation of
aryl hydrocarbon receptor (AhR) signaling. In this study, we investigated the structure-dependent AhR activity of 14
flavonoids in Caco2
colon cancer cells using induction of
CYP1A1 and UGT1A1 gene expression as endpoints. A major structural determinant for AhR activation was the number of
hydroxyl groups where pentahydroxyflavonoids (with the exception of
morin) > hexahydroxyflavonoids > tetra-/trihydroxyflavonoids, and some of the latter compounds such as
apigenin exhibited AhR antagonist activity for induction of
CYP1A1. Simulations suggest that while
quercetin and
apigenin interact primarily with the same residues, the strength of interactions between specific AhR residues with
CYP1A1 agonist,
quercetin, in comparison with
CYP1A1 antagonist,
apigenin, is different; thus, such interactions are presumably indicative of potential switches for modulating
CYP1A1 activity. The structure-dependent effects of the
hydroxyl flavonoids on induction of UGT1A1 were similar to that observed for induction of
CYP1A1 except that
luteolin and
apigenin induced UGT1A1 levels similar to that observed for
TCDD, whereas both compounds were AhR antagonists for
CYP1A1. Thus, the effects of the
flavonoids in Caco2 cells on Ah-responsiveness and interactions with
butyrate were both
ligand structure- and response-dependent and these activities are consistent with hydroxyflavonoids being selective AhR modulators.